clinical_trials
Trio of IgA Nephropathy Drugs Proves Mettle in Interim Analyses
Confidence86·multiple reportsImportance88NP-EVT-20261025-FB42B57
(MedPage Today) -- DENVER -- Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy agents and a third that was recently granted accelerated approval. First, in the RAINIER...
Read the original at the primary source
Trio of IgA Nephropathy Drugs Proves Mettle in Interim Analyses
10/25/2026, 7:53:18 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —